Skip to main content
Premium Trial:

Request an Annual Quote

Shamrock Structures to Provide Structural Proteomics Services for Trubion Pharmaceuticals

NEW YORK, Nov. 19 (GenomeWeb News) -  Shamrock Structures will provide integrated structural proteomics services for Trubion Pharmaceuticals, the company said today.

 

Shamrock, based in Woodridge, Ill., will perform crystallization, collect synchrotron data, and determine the structure of proteins developed by Trubion in return for an upfront fee and performance-based milestone payments.

 

Trubion Pharmaceuticals, based in Seattle, is focused on the discovery and development of drugs to treat inflammatory diseases and cancer.

 

Additional terms were undisclosed.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.